CY2586B2 - Modulators of the function of FAS/APO1 receptors - Google Patents

Modulators of the function of FAS/APO1 receptors

Info

Publication number
CY2586B2
CY2586B2 CY0700017A CY0700017A CY2586B2 CY 2586 B2 CY2586 B2 CY 2586B2 CY 0700017 A CY0700017 A CY 0700017A CY 0700017 A CY0700017 A CY 0700017A CY 2586 B2 CY2586 B2 CY 2586B2
Authority
CY
Cyprus
Prior art keywords
fas
function
modulators
apo1
receptors
Prior art date
Application number
CY0700017A
Other languages
English (en)
Inventor
David Wallach
Mark Boldin
Eugene Varfolomeev
Igor Mett
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11200294A external-priority patent/IL112002A0/xx
Priority claimed from IL112692A external-priority patent/IL112692A/en
Priority claimed from IL11461595A external-priority patent/IL114615A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of CY2586B2 publication Critical patent/CY2586B2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transmitters (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Radar Systems Or Details Thereof (AREA)
CY0700017A 1994-12-15 2007-11-20 Modulators of the function of FAS/APO1 receptors CY2586B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11200294A IL112002A0 (en) 1994-05-11 1994-12-15 Modulatiors of tnf/ngf superfamily receptors, their preparation and use
IL112692A IL112692A (en) 1995-02-19 1995-02-19 ANTIBODIES TO PROTEIN WHICH BINDS TO Fas-R
IL11461595A IL114615A0 (en) 1995-07-16 1995-07-16 Modulators of the function of fas receptors and other proteins

Publications (1)

Publication Number Publication Date
CY2586B2 true CY2586B2 (en) 2009-11-04

Family

ID=27271687

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0700017A CY2586B2 (en) 1994-12-15 2007-11-20 Modulators of the function of FAS/APO1 receptors

Country Status (18)

Country Link
EP (1) EP0871645B1 (da)
JP (1) JP3787355B2 (da)
KR (1) KR100536394B1 (da)
CN (1) CN1105725C (da)
AT (1) ATE377073T1 (da)
AU (1) AU706401B2 (da)
CA (1) CA2207815C (da)
CY (1) CY2586B2 (da)
DE (1) DE69535634T2 (da)
DK (1) DK0871645T3 (da)
ES (1) ES2292172T3 (da)
FI (1) FI121273B (da)
HK (1) HK1007248A1 (da)
MX (1) MX9704501A (da)
NO (1) NO324725B1 (da)
PT (1) PT871645E (da)
UA (1) UA58489C2 (da)
WO (1) WO1996018641A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) * 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
AU755662B2 (en) * 1995-02-22 2002-12-19 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
WO1996025941A1 (en) * 1995-02-22 1996-08-29 Yeda Research And Development Co. Ltd. Modulators of regulatory proteins
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US6399327B1 (en) 1995-07-16 2002-06-04 Yeda Research And Development Co. Ltd. Modulators of the function of FAS receptors and other proteins
US6911526B2 (en) * 1996-07-22 2005-06-28 The Trustees Of Columbia University In The City Of New York Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof
EP0842665A3 (en) * 1996-11-14 2002-12-18 Smithkline Beecham Corporation Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
US5969102A (en) * 1997-03-03 1999-10-19 St. Jude Children's Research Hospital Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
PT977846E (pt) * 1997-04-25 2002-11-29 Wyeth Corp Isoformas de morti neuronal
AU7988698A (en) * 1997-06-26 1999-01-19 Chiron Corporation Human fadd-interacting protein (fip)
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
US6015712A (en) * 1999-07-19 2000-01-18 Isis Pharmaceuticals Inc. Antisense modulation of FADD expression
ATE542545T1 (de) 2001-05-24 2012-02-15 Zymogenetics Inc Taci-immunoglobulin-fusionsproteine
US6743630B2 (en) 2002-03-06 2004-06-01 The Trustees Of Columbia University In The City Of New York Method of preparing a protein array based on biochemical protein-protein interaction
WO2007019573A2 (en) 2005-08-09 2007-02-15 Zymogenetics, Inc. Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
EA016083B1 (ru) 2005-08-09 2012-02-28 Займоджинетикс, Инк. СПОСОБ ЛЕЧЕНИЯ НЕХОДЖКИНСКОЙ ЛИМФОМЫ С ПОМОЩЬЮ СЛИТОЙ МОЛЕКУЛЫ TACI-Ig
CN101489573B (zh) 2006-05-15 2013-05-22 阿雷斯贸易股份有限公司 用TACI-Ig融合分子治疗自身免疫疾病的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO178777C (no) * 1994-05-09 1996-05-29 Kvaerner Eng Varmeveksler
US7807783B1 (en) * 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US5674734A (en) * 1995-05-18 1997-10-07 President And Fellows Of Harvard College Cell death protein

Also Published As

Publication number Publication date
DK0871645T3 (da) 2007-12-03
HK1007248A1 (en) 1999-04-09
CA2207815A1 (en) 1996-06-20
NO972716L (no) 1997-07-11
ES2292172T3 (es) 2008-03-01
WO1996018641A1 (en) 1996-06-20
ATE377073T1 (de) 2007-11-15
CN1105725C (zh) 2003-04-16
EP0871645A4 (en) 1999-11-24
AU4602296A (en) 1996-07-03
FI121273B (fi) 2010-09-15
PT871645E (pt) 2007-11-14
KR100536394B1 (ko) 2006-04-21
AU706401B2 (en) 1999-06-17
EP0871645B1 (en) 2007-10-31
UA58489C2 (uk) 2003-08-15
FI972457A (fi) 1997-06-10
CA2207815C (en) 2011-03-29
CN1169729A (zh) 1998-01-07
JPH10510712A (ja) 1998-10-20
DE69535634T2 (de) 2008-08-28
EP0871645A1 (en) 1998-10-21
FI972457A0 (fi) 1997-06-10
DE69535634D1 (de) 2007-12-13
NO972716D0 (no) 1997-06-12
JP3787355B2 (ja) 2006-06-21
MX9704501A (es) 1997-10-31
NO324725B1 (no) 2007-12-03

Similar Documents

Publication Publication Date Title
CY2586B2 (en) Modulators of the function of FAS/APO1 receptors
AU1750297A (en) Humanized green fluorescent protein genes and methods
AU5099293A (en) CD27 ligand
AU4232696A (en) Novel embryonic cell populations and methods to isolate such populations
MX9801864A (es) Materiales y metodos con relacion a la union y presentacion de substancias sobre superficies de celulas.
EP1074618A3 (en) Cadherin materials and methods
EP1798287A3 (en) Mammalian cell membrane proteins and related reagents
AU750797C (en) Flip gene and flip protein
AU4423799A (en) Methods and agents for modulating the immune response and inflammation involvingmonocyte and dendritic cell membrane proteins
AU3823795A (en) Novel mammalian protein associated with uncontrolled cell division
AU1908395A (en) Antibodies to mammalian natural killer antigens and uses
IL133129A0 (en) Prenylcysteine carboxyl methyltransferase dna encoding same and a method of screening for inhibistors thereof
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
ES8802538A1 (es) Un metodo de producir una proteina capaz de modular la actividad fisiologica de celulas que tienen un receptor de diazepam
AU6292694A (en) Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
AU5657794A (en) Identification of compounds modulations protein/cell membrane association
BG104769A (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
AU9694798A (en) T cell receptor-associated molecules (trams) and methods of use therefor
WO1999047709A3 (en) Methods for identifying anti-cancer agents
AU7324094A (en) Cell surface protein present on nk (natural killer cells) named dx1
AU7718294A (en) Mammalian stromal cell proteins and dna sequences coding therefor
AU9790398A (en) Mrit family of cell death proteins, nucleic acids encoding same, and methods of use
AU547015B2 (en) Methane fermenter
SG148025A1 (en) Modulators of the function of receptors of the tnf/ngf receptor family and other proteins